Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production. The post Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism appeared first on FAIR.
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.